Enhanced Perigraft Angiogenesis Prevents Prosthetic Graft Infection

Annals of Thoracic Surgery

Volumn 86, Issue 4, 2008, Pages 1278-1284

  Sato, Shinichi ^a   Nitta, Yoshio ^a   Saiki, Yoshikatsu ^a   Kawamoto, Shunsuke ^a   Iguchi, Atsushi ^a   Kaku, Mitsuo ^a   Tabata, Yasuhiko ^b   Tabayashi, Koichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; MICROSPHERE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SURGERY; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; HISTOPATHOLOGY; HYDROGEL; INFECTION PREVENTION; INFECTION RATE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PROBABILITY; PROSTHESIS-RELATED INFECTIONS; RANDOM ALLOCATION; RATS; RATS, INBRED F344; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 52049114926     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.03.035     Document Type: Article

References (26)

1. Coselli J.S., Köksoy C., and LeMaire S.A. Management of thoracic aortic graft infections. Ann Thorac Surg 67 (1999) 1990-1993
2. LeMaire S.A., and Coselli J.S. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg 134 (2007) 839-843
3. Shrager J.B., Wain J.C., Wright C.D., et al. Omentum is highly effective in the management of complex cardiothoracic surgical problems. J Thorac Cardiovasc Surg 125 (2003) 526-532
4. Saiki Y., Hata M., Akasaka J., Saito T., and Tabayashi K. Vacuum-assisted closure system for the treatment of mediastinitis after total aortic arch replacement. Jpn J Thorac Cardiovasc Surg 53 (2005) 638-640
5. Fuchs U., Zittermann A., Stuettgen B., Groening A., Minami K., and Koerfer R. Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared with conventional therapy with open packing: a retrospective analysis. Ann Thorac Surg 79 (2005) 526-531
6. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
7. Baumgartner I., Pieczek A., Manor O., et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 (1998) 1114-1123
8. Lazarous D.F., Unger E.F., Epstein S.E., et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 36 (2000) 1239-1244
9. Lederman R.J., Mendelsohn F.O., Anderson R.D., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359 (2002) 2053-2058
10. Kawai K., Suzuki S., Tabata Y., and Nishimura Y. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg 58 (2005) 1115-1123
11. Ueyama K., Bing G., and Tabata Y. Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg 127 (2004) 1608-1615
12. Iwakura A., Tabata Y., Miyao M., et al. Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor. Circulation 102 (2000) III307-III311
13. Ohki Y., Heissig B., Sato Y., et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 19 (2005) 2005-2007
14. Rajagopalan S., Mohler III E.R., Lederman R.J., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108 (2003) 1933-1938
15. Liu Y., Sun L., Huan Y., Zhao H., and Deng J. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg 30 (2006) 103-107
16. Ghiselli R., Giacometti A., Cirioni O., et al. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg 36 (2002) 1027-1030
17. Tabata Y., Hijikata S., and Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 31 (1994) 189-199
18. Iwakura A., Fujita M., Kataoka K., et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 18 (2003) 93-99
19. Bandyk D.F., Novotney M.L., Johnson B.L., Back M.R., and Roth S.R. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 95 (2001) 44-49
20. Sato S., Saiki Y., Nitta Y., Oda K., Takahashi G., and Tabayashi K. Redo total aortic arch replacement using an extended homograft for graft infection. Jpn J Thorac Cardiovasc Surg 54 (2006) 448-450
21. Sakaguchi H., Marui A., Hirose K., et al. Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin. J Thorac Cardiovasc Surg 135 (2008) 25-31
22. Hirose K., Marui A., Arai Y., et al. A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice. Heart Vessels 22 (2007) 261-267
23. Hayek A., Culler F.L., Beattie G.M., Lopez A.D., Cuevas P., and Baird A. An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun 147 (1987) 876-880
24. Burgess W.H., and Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58 (1989) 575-606
25. Rifkin D.B., and Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109 (1989) 1-6
26. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436